BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28160367)

  • 1. Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course.
    Heß K; Purrucker J; Hegenbart U; Brokinkel B; Berndt R; Keyvani K; Monoranu CM; Löhr M; Reifenberger G; Munoz-Bendix C; Kalla J; Groß J; Schick U; Kollmer J; Klapper W; Röcken C; Hasselblatt M; Paulus W
    Brain Pathol; 2018 Mar; 28(2):234-239. PubMed ID: 28160367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
    Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
    Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AL Amyloidoma of the Skin/Subcutis: Cutaneous Amyloidosis, Plasma Cell Dyscrasia or a Manifestation of Primary Cutaneous Marginal Zone Lymphoma?
    Walsh NM; Lano IM; Green P; Gallant C; Pasternak S; Ly TY; Requena L; Kutzner H; Chott A; Cerroni L
    Am J Surg Pathol; 2017 Aug; 41(8):1069-1076. PubMed ID: 28505007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyloidoma of the central nervous system: CT and MR aspects].
    Smadja P; Viaud B; Durand L; Bauchet L; Bossot P; Hane B; Campello C; Bonafé A
    J Radiol; 2000 Sep; 81(9):975-8. PubMed ID: 10992096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of immunoglobulin light-chain restriction in cutaneous B-cell lymphomas by ultrasensitive bright-field mRNA in situ hybridization.
    Minca EC; Wang H; Wang Z; Lanigan C; Billings SD; Luo Y; Tubbs RR; Ma XJ
    J Cutan Pathol; 2015 Feb; 42(2):82-9. PubMed ID: 25363373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-restricted amyloidoma of immunoglobulin lambda-light chain origin clinically resembling multiple sclerosis.
    Linke RP; Gerhard L; Lottspeich F
    Biol Chem Hoppe Seyler; 1992 Dec; 373(12):1201-9. PubMed ID: 1292505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloidoma of bone, a plasma cell/plasmacytoid neoplasm. Report of three cases and review of the literature.
    Pambuccian SE; Horyd ID; Cawte T; Huvos AG
    Am J Surg Pathol; 1997 Feb; 21(2):179-86. PubMed ID: 9042284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Ossifying Amyloidoma.
    Requena C; Diago A; Traves V; Llombart B; Nagore E; Sanmartin O
    Am J Dermatopathol; 2022 Oct; 44(10):760-763. PubMed ID: 35925553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral A lambda amyloidoma diagnosed by stereotactic biopsy.
    Schröder R; Linke RP; Voges J; Heindel W; Sturm V
    Clin Neuropathol; 1995; 14(6):347-50. PubMed ID: 8605742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Amyloidoma.
    Maheux A; Savatovsky J; Lecler A
    World Neurosurg; 2019 May; 125():449-450. PubMed ID: 30738933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AL amyloidosis with a localized B cell neoplasia.
    Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
    Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic and Proteomic Analysis of Amyloidomas Involving the Ocular Surface and Adnexa.
    Jamshidi P; Levi J; Suarez MJ; Rivera R; Mahoney N; Eberhart CG; Rosenberg A; Rodriguez FJ
    Am J Clin Pathol; 2022 Apr; 157(4):620-627. PubMed ID: 34698334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder.
    Grogg KL; Aubry MC; Vrana JA; Theis JD; Dogan A
    Am J Surg Pathol; 2013 Mar; 37(3):406-12. PubMed ID: 23282974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cervical amyloidoma: a case report and review of the literature.
    Werner BC; Shen FH; Shimer AL
    Spine J; 2013 Oct; 13(10):e1-7. PubMed ID: 23669122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral AL lambda-amyloidoma: clinical and pathomorphological characteristics. Review of the literature and of a patient.
    Fischer B; Palkovic S; Rickert C; Weckesser M; Wassmann H
    Amyloid; 2007 Mar; 14(1):11-9. PubMed ID: 17453621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral amyloidoma: case report and review of the literature.
    Foreid H; Barroso C; Evangelista T; Campos A; Pimentel J
    Clin Neuropathol; 2010; 29(4):217-22. PubMed ID: 20569671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary amyloidoma of the brain parenchyma.
    Tabatabai G; Baehring J; Hochberg FH
    Arch Neurol; 2005 Mar; 62(3):477-80. PubMed ID: 15767515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren syndrome-related plasma cell disorder and multifocal nodular AL amyloidosis: clinical picture and pathological findings.
    Ikeda SI; Hineno A; Yoshinaga T; Matsuo K; Suga T; Shiina T; Otsuki T; Hoshii Y
    Amyloid; 2019 Dec; 26(4):225-233. PubMed ID: 31530196
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
    Magro C; Crowson AN; Porcu P; Nuovo GJ
    J Cutan Pathol; 2003 Sep; 30(8):504-11. PubMed ID: 12950502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral amyloidoma diagnosed intraoperatively with squash preparations: a case report.
    Meir K; Maly B; Shoshan Y; Maly A; Soffer D
    Acta Cytol; 2005; 49(2):195-8. PubMed ID: 15839628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.